New drug application

From DISI

Jump to: navigation, search

A new drug application (NDA) is an application submitted by the manufacturer of a drug to the FDA - after clinical trials have been completed - for a license to market the drug for a specified indication.

Retrieved from "http://wiki.compbio.ucsf.edu/wiki/index.php/New_drug_application"